Kazia Share Price, page-482

Book value at the time R&P......this is what they actually achieved.

Sydney, 19 March 2019 – Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it has entered into an arrangement to sell the remainder of its holding in the ordinary shares of Noxopharm Limited via a single block trade. Kazia expects the transaction to yield proceeds of approximately $2.1m, bringing the total gross proceeds from sale of our holding to approximately $2.4m. The proceeds of the transaction will be applied to Kazia’s own R&D programs, each of which will be yielding important data read-

____________________

Anyway that is not important. I would have given the rights to NOX for nicks...... such that efforts to develop the drug, (and help people) could further proceed... Peanuts either way, not the big game.

But now getting down to more relevant and pertinent matters. (and touchy issues, I guess)

What is happening over is with the drug first developed by own company.

It is exactly the same technology that makes up our Cantrixil.

So are the management of KZA going to disclose, in accordance with their ASX obligations. (At least when the NOX poster is made availalbe).

20/1 they will. Please surprise me CEO and we greeted with complimentary praise.

90% of investors in KZA (or potential investors would not have any idea of what is happening with NOX and the association of our drug Cantrixil) Yon need to tell the market/disclose in accordance with Company obligations.

I am sick of it....and my name features in a number of files at ASIC. It is the perfect right for investors to present their concerns, with regard to disclosure. And again correspondence may be forwarded to ASIC on this matter.

However no such action regardless of more of the same from this management will be undertaken by myself..... until post April. Look anything can happen in April at AACR, when these likely 3 sets of positive data released.

When I say anything....even with this extreme SP laggard of a company.....$8 SP after could be on - market cap US$650M would be fat too cheap, but even I would take that. So give it post AACR and see what happens. Better still, the company to do something now and no need for ASIC.

Not too sure they will be buying on market anytime soon....it just shuts down news flow, for a couple of months.... in the minds of traders/investors at least.

I think they are becoming SP conscious, and so management should be.

The 2 months is almost up. They have "things" up their sleeve, I believe would could unleash a proverbial SP storm. Stop treating us like mushrooms and disclosure.